IWAG
RNTX

Integer Wealth Advisors Group’s Rein Therapeutics RNTX Stock Holding History

Integer Wealth Advisors Group’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$43K Hold
1,590
– – 0.02% 81
2020
Q4 		$39K Hold
1,590
– – 0.03% 78
2020
Q3 		$41K Hold
1,590
– – 0.04% 69
2020
Q2 		$36K Hold
1,590
– – 0.04% 66
2020
Q1 		$17K Hold
1,590
– – 0.02% 63
2019
Q4 		$21K Buy
+1,590
New +$15.7K 0.02% 64

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Integer Wealth Advisors Group's RNTX Position: Q1 2021 in Review

Integer Wealth Advisors Group held its Rein Therapeutics (RNTX) position steady in Q1 2021 at 1,590 shares worth $43K. The position accounts for 0.02% of the portfolio, ranked #81.

Integer Wealth Advisors Group first reported a position in RNTX in Q4 2019 and has held it in 6 quarters since. 52 funds tracked by Wall St. Rank hold RNTX as of Q1 2021.

  • Integer Wealth Advisors Group held 1,590 shares of Rein Therapeutics worth $43K as of Q1 2021.
  • Integer Wealth Advisors Group left its Rein Therapeutics share count unchanged in Q1 2021.
  • Rein Therapeutics made up 0.02% of Integer Wealth Advisors Group's portfolio in Q1 2021, its #81 holding.
  • Integer Wealth Advisors Group first reported a position in Rein Therapeutics in Q4 2019 and has held it in 6 quarters since.
  • 52 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2021.

Based on Integer Wealth Advisors Group's 13F filing for Q1 2021, filed 12 Apr 2021.